{
    "2019-07-02": [
        [
            {
                "time": "2018-01-02",
                "original_text": "Pfizer's Eucrisa Proves Safety in Kids with Atopic Dermatitis",
                "features": {
                    "keywords": [
                        "Pfizer",
                        "Eucrisa",
                        "Safety",
                        "Kids",
                        "Atopic Dermatitis"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2018-01-02",
                "original_text": "13 Blue-Chip Stocks With Risks You Need to Watch",
                "features": {
                    "keywords": [
                        "Blue-Chip",
                        "Stocks",
                        "Risks",
                        "Watch"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "diverse"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-01-02",
                "original_text": "Gilead to Submit NDA for Inflammation Drug Filgotinib in '19",
                "features": {
                    "keywords": [
                        "Gilead",
                        "NDA",
                        "Inflammation",
                        "Drug",
                        "Filgotinib"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "biotechnology"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            }
        ]
    ]
}